Explore

Trendline Trendline
Skape Bio Utilizes AI for Breakthroughs in GPCR Drug Design, Targeting Undruggable Diseases

Skape Bio Utilizes AI for Breakthroughs in GPCR Drug Design, Targeting Undruggable Diseases

Skape Bio Utilizes AI for Breakthroughs in GPCR Drug Design, Targeting Undruggable Diseases
Trendline Trendline
AI-Designed Miniprotein Switches Offer New Approach to GPCR Targeting

AI-Designed Miniprotein Switches Offer New Approach to GPCR Targeting

AI-Designed Miniprotein Switches Offer New Approach to GPCR Targeting
Trendline Trendline
AI-Designed Miniproteins Offer New Hope for Treating Hard-to-Treat Diseases

AI-Designed Miniproteins Offer New Hope for Treating Hard-to-Treat Diseases

AI-Designed Miniproteins Offer New Hope for Treating Hard-to-Treat Diseases
Trendline Trendline
AI and Biologics Converge at 'Closing the Loop SF 2026' Event

AI and Biologics Converge at 'Closing the Loop SF 2026' Event

AI and Biologics Converge at 'Closing the Loop SF 2026' Event
Trendline Trendline
Imperagen Secures $6.7 Million to Innovate Enzyme Engineering with AI and Quantum Physics

Imperagen Secures $6.7 Million to Innovate Enzyme Engineering with AI and Quantum Physics

Imperagen Secures $6.7 Million to Innovate Enzyme Engineering with AI and Quantum Physics
Trendline Trendline
Imperagen Secures $6.7 Million to Revolutionize Enzyme Engineering with AI and Quantum Physics

Imperagen Secures $6.7 Million to Revolutionize Enzyme Engineering with AI and Quantum Physics

Imperagen Secures $6.7 Million to Revolutionize Enzyme Engineering with AI and Quantum Physics
Trendline Trendline
Imperagen Secures $6.7 Million to Revolutionize Enzyme Engineering

Imperagen Secures $6.7 Million to Revolutionize Enzyme Engineering

Imperagen Secures $6.7 Million to Revolutionize Enzyme Engineering
Trendline Trendline
Skape Bio Unveils AI-Driven Platform for GPCR Biotherapeutics, Promising New Drug Development Pathways

Skape Bio Unveils AI-Driven Platform for GPCR Biotherapeutics, Promising New Drug Development Pathways

Skape Bio Unveils AI-Driven Platform for GPCR Biotherapeutics, Promising New Drug Development Pathways
Trendline Trendline
Collaborative Drug Discovery and Eli Lilly Partner to Boost Biotech Innovation

Collaborative Drug Discovery and Eli Lilly Partner to Boost Biotech Innovation

Collaborative Drug Discovery and Eli Lilly Partner to Boost Biotech Innovation
Trendline Trendline
IGC Pharma Advances Alzheimer's Treatment with CALMA Phase 2 Trial Progress

IGC Pharma Advances Alzheimer's Treatment with CALMA Phase 2 Trial Progress

IGC Pharma Advances Alzheimer's Treatment with CALMA Phase 2 Trial Progress
Trendline Trendline
Collaborative Drug Discovery Partners with Eli Lilly to Enhance Biotech Innovation

Collaborative Drug Discovery Partners with Eli Lilly to Enhance Biotech Innovation

Collaborative Drug Discovery Partners with Eli Lilly to Enhance Biotech Innovation
Trendline Trendline
Thermo Fisher Scientific Showcases Growth Strategy and AI Integration at Investor Day

Thermo Fisher Scientific Showcases Growth Strategy and AI Integration at Investor Day

Thermo Fisher Scientific Showcases Growth Strategy and AI Integration at Investor Day